Komori
Human Metabolome Technologies (6090) · FactAdvanced

Deliberation of Director Appointments and Compensation by a Voluntary Nomination and Compensation Committee

First written in FY2019. 3 of 5 entries say "Advanced", first in FY2020. Latest entry: FY2024.

5entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2019AdvancedFY2020RestatedFY2021AdvancedFY2023 – FY20242019: 120192020: 120202021: 120212022: 020222023: 120232024: 12024
Same theme, other companies
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 198 companies compared. The sentences above are computed from all 198.Comparing 200 of the theme's 675 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2024AdvancedAnnual report

    「During the fiscal year under review, the company held 9 meetings of the nomination committee. Attendance by each director was as follows.」

    The voluntary nomination committee met 9 times and the compensation committee 6 times, and the composition of the committees was also changed in connection with changes to the management structure.
  2. FY2023AdvancedAnnual report

    「The committees met 4 times during the fiscal year ended June 2023 (July 2022 to June 2023), and all committee members attended.」

    For the voluntary nomination and compensation committees, the company disclosed that the nomination committee met 4 times and the compensation committee 2 times, with all committee members attending, providing specific details of their operating record.
  3. FY2021RestatedAnnual report

    「We have established a voluntary nomination committee composed of the following directors, including outside directors. The nomination committee deliberates on the composition of the Board of Directors, the appointment of director candidates and other matters.」

    The company operates voluntary nomination and compensation committees with outside directors among their members and has them deliberate on director appointments and compensation.
  4. FY2020AdvancedAnnual report

    「During the fiscal year under review, the nomination committee met on 8 August 2019 and the compensation committee met on 21 September 2019.」

    For the voluntary nomination and compensation committees, the company disclosed their composition, matters deliberated and meeting record for the fiscal year under review, providing more specific details of their operation.
  5. FY2019First statedAnnual report

    「We have established voluntary nomination and compensation committees composed of the following directors, including outside directors.」

    The company described the establishment of voluntary committees to deliberate policies for the appointment and dismissal of director candidates and the structure and payment standards for compensation.
Moved together

"Productivity Improvement in Analytical Work" moved the same way as this thread, in the same document, in 3 of its 5 moves.

332222★123456
  1. ★This thread
  2. 1Productivity Improvement in Analytical Work3×
  3. 2Capital investment to expand analytical capabilities and accelerate research and development3×
  4. 3Proactive Talent Acquisition and Organizational Revitalization2×
  5. 4Expansion of Orders for the Metabolome Analysis Business2×
  6. 5Development of New Markets Related to Foods with Function Claims and Other Areas2×
  7. 6Further Penetration of Overseas Markets and Winning Orders in Asia2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Human Metabolome Technologies yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Deliberation of Director Appointments and Compensation by a Voluntary Nomination and Compensation Committee | Human Metabolome Technologies,Inc. (6090) | Komori